Hansson, O;
Cullen, N;
Zetterberg, H;
Blennow, K;
Mattsson-Carlgren, N;
(2020)
Plasma phosphorylated tau181 and neurodegeneration in Alzheimer's disease.
Annals of Clinical and Translational Neurology
10.1002/acn3.51253.
(In press).
Preview |
Text
acn3.51253.pdf - Published Version Download (23MB) | Preview |
Abstract
We examined if plasma phosphorylated tau is associated with neurodegeneration in Alzheimer’s disease. We investigated 372 cognitively unimpaired participants, 554 mild cognitive impairment patients, and 141 Alzheimer’s disease dementia patients. Tau phosphorylated at threonine 181, regional cortical thickness (using magnetic resonance imaging) and hypometabolism (using fluorodeoxyglucose positron emission tomography) were measured longitudinally. High plasma tau was associated with hypometabolism and cortical atrophy at baseline and over time, and longitudinally increased tau was associated with accelerated atrophy, but these associations were only observed in Aβ‐positive participants. Plasma phosphorylated tau may identify and track processes linked to neurodegeneration in Alzheimer’s disease.
Type: | Article |
---|---|
Title: | Plasma phosphorylated tau181 and neurodegeneration in Alzheimer's disease |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1002/acn3.51253 |
Publisher version: | https://doi.org/10.1002/acn3.51253 |
Language: | English |
Additional information: | Copyright © 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
URI: | https://discovery.ucl.ac.uk/id/eprint/10116900 |
Archive Staff Only
View Item |